![](http://www.genomicseducation.hee.nhs.uk/wp-content/uploads/2024/02/Cancer-cells_1350x450-450x150.jpg)
NICE recommendations broaden patient access to cancer drug olaparib
The use of the targeted therapy has been expanded to include certain types of breast, prostate, ovarian, fallopian tube and primary peritoneal cancers
![](http://www.genomicseducation.hee.nhs.uk/wp-content/uploads/2022/08/DNA-pharmacogenomics_17410190_900px-450x150.jpg)
How the NHS will embed genomics into pharmacy practice
We take a closer look at the new three-year strategic framework for integrating genomic medicine into pharmacy education and training
![Conceptual illustration of neuron cells with glowing link knots in abstract dark space, high resolution 3D illustration](http://www.genomicseducation.hee.nhs.uk/wp-content/uploads/2024/01/neurology-banner-450x150.jpg)
Clinical trials show promise for first ‘gene silencing’ treatment for Alzheimer’s disease
A new RNA-based therapy for Alzheimer’s disease that's in clinical trial phase could be the first of its kind to use ‘gene silencing’ for the condition
![](http://www.genomicseducation.hee.nhs.uk/wp-content/uploads/2024/01/Personalisation-of-Cancer-Care-450x150.jpg)
How hearing patient experiences levels up genomics training
Incorporating patient voices in genomics education can help healthcare professionals see the human impact of genomics. Here are some examples from our own work
![](http://www.genomicseducation.hee.nhs.uk/wp-content/uploads/2020/05/bloodsample_1350x450-450x150.jpg)
World-first gene therapy trial for Hunter syndrome opens
We explore a new treatment that aims to cross the blood-brain barrier for the first time in Hunter syndrome